Home
Home » companies

Cornerstone Therapeutics

9 Pharmaceutical Stocks to Sell Now

9 Pharmaceutical Stocks to Sell Now
InvestorPlace

Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan

Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan
Yahoo/AP

Is This Drug Taking on Water?

Is This Drug Taking on Water?
Motley Fool

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville

What to Expect from Cornerstone Therapeutics

What to Expect from Cornerstone Therapeutics
Motley Fool

Cornerstone Therapeutics buys IV blood pressure drug maker EKR in deal worth up to $150M

Cornerstone Therapeutics buys IV blood pressure drug maker EKR in deal worth up to $150M
Yahoo/AP

Cornerstone Therapeutics says FDA begins review of treatment for low blood sodium levels

Cornerstone Therapeutics says FDA begins review of treatment for low blood sodium levels
Yahoo/AP

Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants

Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
Sacramento Bee, Ca

Cornerstone Therapeutics 3Q profit slips

Cornerstone Therapeutics 3Q profit slips
Yahoo/AP

6 Biotech Stocks With A History Of Earnings Surprises

6 Biotech Stocks With A History Of Earnings Surprises
Seeking Alpha